Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
Yun‐Fan Liaw(Chang Gung Memorial Hospital), Elizabeth Cooney(Bristol-Myers Squibb (United States)), M. Raptopoulou‐Gigi(Aristotle University of Thessaloniki), Shiv Kumar Sarin(Institute of Liver and Biliary Sciences), Jolanta Białkowska(Medical University of Lodz), Nancy Leung(North Bristol NHS Trust), Cheng‐Yuan Peng(China Medical University), Tawesak Tanwandee(Siriraj Hospital), Shijie Tang(Shantou University), Robert P. Myers(Meta (United States)), Naoky Tsai(University of Hawaiʻi at Mānoa), Lennox J. Jeffers(University of Miami), Robert S. Brown(Cornell University), S. P. Beebe(Bristol-Myers Squibb (United States)), Hugo Cheinquer(Universidade Federal do Rio Grande do Sul)
Cited by 231
Related Papers
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
|Hepatology International|2017|2.2k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Transmissibility and transmission of respiratory viruses
|Nature Reviews Microbiology|2021|910
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
|Hepatology International|2008|870